Clinical Trials on Breast Cancer in Situ in Hungary
Total 661 results
-
National Institute of Oncology, HungaryUnknownInvasive Breast Cancer | in Situ Breast CancerHungary
-
National Institute of Oncology, HungaryCompleted
-
National Institute of Oncology, HungaryCompleted
-
National Institute of Oncology, HungaryNot yet recruiting
-
Central European Cooperative Oncology GroupTerminatedMetastatic Breast CancerHungary, Austria
-
National Institute of Oncology, HungaryActive, not recruitingBreast Cancer | Radiation Toxicity | Side EffectsHungary
-
Queen Mary University of LondonCancer Research UKCompletedBreast CancerFrance, Switzerland, Ireland, United Kingdom, Italy, Australia, Austria, Belgium, Chile, Germany, Hungary, Malta, Sweden, Turkey
-
Semmelweis UniversityRecruitingHER2-negative Breast CancerHungary
-
Central European Cooperative Oncology GroupCompletedBreast CancerAustria, Hungary, Poland, Slovakia
-
PfizerHospira, now a wholly owned subsidiary of PfizerCompletedNon-metastatic Breast CancerHungary, Spain
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); Breast International GroupTerminatedBreast CancerSwitzerland, Italy, Hungary
-
AstraZenecaCompleted
-
Genzyme, a Sanofi CompanyCompletedAdvanced Breast CancerSouth Africa, Sweden, Hungary, Taiwan, Spain
-
Hoffmann-La RocheCompleted
-
ERYtech PharmaTerminatedTriple Negative Breast CancerSpain, Belgium, Hungary
-
GlaxoSmithKlineCompleted
-
University of Erlangen-Nürnberg Medical SchoolUnknownBreast CancerAustria, Germany, Hungary, Poland, Spain
-
Hoffmann-La RocheCompletedMetastatic Breast CancerHungary
-
Carrick Therapeutics LimitedPfizerRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerSpain, United States, Turkey, Hungary
-
Prestige Biopharma LimitedCompletedHER2 Positive Breast CancerSpain, Malaysia, Estonia, Hungary, Thailand, Belarus, Bulgaria, France, Georgia, Italy, Poland, Russian Federation, Ukraine
-
Hoffmann-La RocheCompleted
-
PfizerTerminatedBreast CancerUnited States, Belgium, Hungary, China, Hong Kong, Poland, Singapore
-
Hoffmann-La RocheCompleted
-
Acrotech Biopharma Inc.CompletedBreast Cancer | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Human Mammary CarcinomaFrance, United States, Czechia, Hungary
-
Eli Lilly and CompanyCompletedBreast CancerBrazil, Greece, Hungary, Peru, Poland, Spain, Venezuela
-
Spanish Breast Cancer Research GroupPfizer; AstraZenecaCompletedMetastatic Breast CancerSpain, Israel, Hungary, Austria
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerBelgium, Turkey, Canada, Poland, Romania, Hungary, France, Czechia
-
BayerActive, not recruitingHot Flashes | Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast CancerSpain, France, Belgium, United Kingdom, Hungary, Israel, Italy, Ireland, Germany, Portugal, Finland, Poland, Romania, Canada, Austria, Kazakhstan
-
Bristol-Myers SquibbCompletedBreast CancerAustralia, Hungary, Canada, United Kingdom, Belgium
-
Eli Lilly and CompanyCompletedBreast CancerAustria, Czech Republic, Hungary, Poland, Romania, Russian Federation
-
AstraZenecaCompleted
-
AstraZenecaCompletedFGFR Inhibition, Pharmacokinetics, Biomarkers | ER+ Breast CancerCzech Republic, Italy, United Kingdom, Hungary, Germany, Romania, Belgium, France
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Patient SatisfactionHungary
-
Queen Mary University of LondonAstraZeneca; Cancer Research UKUnknownMetastatic Breast CancerKorea, Republic of, United Kingdom, Hungary, Georgia, France, Romania
-
MedSIRHoffmann-La RocheActive, not recruitingEarly Breast CancerSpain, Italy, Germany, Bulgaria, Hungary
-
PfizerTerminatedAdvanced Breast CancerUnited States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSpain, Switzerland, Hungary, France, Italy, Peru, Portugal, Sweden
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Early-stage Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Institut de Recherches Internationales ServierBreast International GroupCompletedBreast CancerUnited Kingdom, Italy, France, Belgium, Australia, Canada, Germany, Hungary, Spain
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
University Hospital, Basel, SwitzerlandETOP IBCSG Partners Foundation; Austrian Breast Cancer Study GroupRecruitingNode-positive Breast CancerGreece, Switzerland, Hungary, Austria, Germany, Italy, Lithuania, Argentina, Croatia
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedBreast CancerSpain, Poland, Italy, Austria, Russian Federation, Slovakia, Hungary, Germany, Czech Republic, Estonia, Latvia
-
GlaxoSmithKlineWithdrawnNeoplasms, BreastHungary, Norway, Austria, Spain
-
PfizerCompletedEarly Breast CancerCzechia, Serbia, Slovakia, United States, Belarus, Hungary, Ukraine, Italy, Poland, Russian Federation
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSwitzerland, Australia, Slovenia, Italy, Sweden, Hungary, Israel, South Africa, New Zealand
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Mastectomy; LymphedemaHungary
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Patient Satisfaction | Mastectomy; LymphedemaHungary
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
ETOP IBCSG Partners FoundationTerminatedBreast CancerItaly, Australia, Belgium, Switzerland, Slovenia, Hungary, Sweden, New Zealand, Romania